BACKGROUND: Trials of new technologies to remotely monitor for signs and symptoms of worsening heart failure are continually emerging. The extent to which technological differences impact the effectiveness of noninvasive remote monitoring for heart failure management is unknown. This study examined the effect of specific technology used for noninvasive remote monitoring of people with heart failure on all-cause mortality and heart failure-related hospitalizations. MATERIALS AND METHODS: A subanalysis of a large systematic review and meta-analysis was conducted. Studies were stratified according to the specific type of technology used, and separate meta-analyses were performed. Four different types of noninvasive remote monitoring technologies were identified, including structured telephone calls, videophone, interactive voice response devices, and telemonitoring. RESULTS: Only structured telephone calls and telemonitoring were effective in reducing the risk of all-cause mortality (relative risk [RR]=0.87; 95% confidence interval [CI], 0.75-1.01; p=0.06; and RR=0.62; 95% CI, 0.50-0.77; p<0.0001, respectively) and heart failure-related hospitalizations (RR=0.77; 95% CI, 0.68-0.87; p<0.001; and RR=0.75; 95% CI, 0.63-0.91; p=0.003, respectively). More research data are required for videophone and interactive voice response technologies. CONCLUSIONS: This subanalysis identified that only two of the four specific technologies used for noninvasive remote monitoring in heart failure improved outcomes. When results of studies that involved these disparate technologies were combined in previous meta-analyses, significant improvements in outcomes were identified. As such, this study has highlighted implications for future meta-analyses of randomized controlled trials focused on evaluating the effectiveness of remote monitoring in heart failure.
BACKGROUND: Trials of new technologies to remotely monitor for signs and symptoms of worsening heart failure are continually emerging. The extent to which technological differences impact the effectiveness of noninvasive remote monitoring for heart failure management is unknown. This study examined the effect of specific technology used for noninvasive remote monitoring of people with heart failure on all-cause mortality and heart failure-related hospitalizations. MATERIALS AND METHODS: A subanalysis of a large systematic review and meta-analysis was conducted. Studies were stratified according to the specific type of technology used, and separate meta-analyses were performed. Four different types of noninvasive remote monitoring technologies were identified, including structured telephone calls, videophone, interactive voice response devices, and telemonitoring. RESULTS: Only structured telephone calls and telemonitoring were effective in reducing the risk of all-cause mortality (relative risk [RR]=0.87; 95% confidence interval [CI], 0.75-1.01; p=0.06; and RR=0.62; 95% CI, 0.50-0.77; p<0.0001, respectively) and heart failure-related hospitalizations (RR=0.77; 95% CI, 0.68-0.87; p<0.001; and RR=0.75; 95% CI, 0.63-0.91; p=0.003, respectively). More research data are required for videophone and interactive voice response technologies. CONCLUSIONS: This subanalysis identified that only two of the four specific technologies used for noninvasive remote monitoring in heart failure improved outcomes. When results of studies that involved these disparate technologies were combined in previous meta-analyses, significant improvements in outcomes were identified. As such, this study has highlighted implications for future meta-analyses of randomized controlled trials focused on evaluating the effectiveness of remote monitoring in heart failure.
Authors: Aaron Conway; Sally C Inglis; Anne M Chang; Margaret Horton-Breshears; John G F Cleland; Robyn A Clark Journal: J Telemed Telecare Date: 2013-09-25 Impact factor: 6.184
Authors: Ross T Tsuyuki; Miriam Fradette; Jeffrey A Johnson; Tammy J Bungard; Dean T Eurich; Thomas Ashton; Wendy Gordon; Roland Ikuta; Jan Kornder; Elizabeth Mackay; Dante Manyari; Ken O'Reilly; William Semchuk Journal: J Card Fail Date: 2004-12 Impact factor: 5.712
Authors: Autumn Dawn Galbreath; Richard A Krasuski; Brad Smith; Karl C Stajduhar; Michael D Kwan; Robert Ellis; Gregory L Freeman Journal: Circulation Date: 2004-11-07 Impact factor: 29.690
Authors: Robert Frank DeBusk; Nancy Houston Miller; Kathleen Marie Parker; Albert Bandura; Helena Chmura Kraemer; Daniel Joseph Cher; Jeffrey Alan West; Michael Bruce Fowler; George Greenwald Journal: Ann Intern Med Date: 2004-10-19 Impact factor: 25.391
Authors: Lee R Goldberg; John D Piette; Mary Norine Walsh; Theodore A Frank; Brian E Jaski; Andrew L Smith; Raymond Rodriguez; Donna M Mancini; Laurie A Hopton; E John Orav; Evan Loh Journal: Am Heart J Date: 2003-10 Impact factor: 4.749
Authors: Christopher Park; Emamuzo Otobo; Jennifer Ullman; Jason Rogers; Farah Fasihuddin; Shashank Garg; Sarthak Kakkar; Marni Goldstein; Sai Vishudhi Chandrasekhar; Sean Pinney; Ashish Atreja Journal: JMIR Med Inform Date: 2019-11-15
Authors: Hang Ding; Sheau Huey Chen; Iain Edwards; Rajiv Jayasena; James Doecke; Jamie Layland; Ian A Yang; Andrew Maiorana Journal: J Med Internet Res Date: 2020-11-13 Impact factor: 5.428